
Edgewise Therapeutics Investor Relations Material
Latest events

Study Result
Edgewise Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Edgewise Therapeutics Inc
Access all reports
Edgewise Therapeutics Inc. (EWTX) is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative treatments for severe, rare muscle disorders, addressing significant unmet medical needs. Utilizing its proprietary drug discovery platform, Edgewise focuses on targeting the muscle as an organ, combining expertise in muscle biology and small molecule engineering. This approach allows the identification of precision medicines regulating key proteins in muscle tissue. Edgewise Therapeutics is headquartered in Boulder, Colorado, and its shares are listed on the Nasdaq.
Key slides for Edgewise Therapeutics Inc


43rd Annual J.P. Morgan Healthcare Conference 2025
Edgewise Therapeutics Inc


Study Update
Edgewise Therapeutics Inc
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
EWTX
Country
🇺🇸 United States